VLON Insider Transactions
| Transaction Date (SEC Report) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2023-09-22 | Kelly Leanne | officer: Chief Financial Officer | 83,333 | A-Award | A | 83,333 | 1.52 | 126,666.00 |
| 2023-08-10 | Szekeres David Leslie | director | 34,483 | A-Award | A | 34,483 | 2.90 | 100,001.00 |
| 2023-08-10 | SIMPSON CAMILLA V | director | 34,483 | A-Award | A | 34,483 | 2.90 | 100,001.00 |
| 2023-08-10 | Rongen Roelof | director | 34,483 | A-Award | A | 34,483 | 2.90 | 100,001.00 |
| 2023-08-10 | Baker David Charles | director | 34,483 | A-Award | A | 34,483 | 2.90 | 100,001.00 |
| 2023-04-21 | Chaturvedi Vipin | officer | 0 | 0 | 0.00 | 0.00 | ||
| 2023-04-21 | SIMPSON CAMILLA V | director: | 0 | 0 | 0.00 | 0.00 | ||
| 2023-04-21 | Agro Albert | officer | 0 | 0 | 0.00 | 0.00 | ||
| 2023-04-21 | Rongen Roelof | director: | 0 | 0 | 0.00 | 0.00 | ||
| 2023-04-21 | Hertz Walter Marc | director, 10 percent owner, officer: Chief Executive Officer | 0 | 0 | 0.00 | 0.00 | ||
| 2023-04-21 | Hertz Walter Marc | director, 10 percent owner, officer: Chief Executive Officer | 385,510 | A-Award | A | 385,510 | 0.00 | 0.00 |
| 2023-04-21 | Agro Albert | officer: Chief Medical Officer | 172,189 | A-Award | A | 172,189 | 0.00 | 0.00 |
| 2023-04-21 | Chaturvedi Vipin | officer: Chief Scientific Officer | 172,189 | A-Award | A | 172,189 | 0.00 | 0.00 |
| 2023-04-21 | Szekeres David Leslie | director: | 0 | 0 | 0.00 | 0.00 | ||
| 2022-12-13 | Thorell Marella | director | 9,506 | J-Other | D | 28,517 | 0.00 | 0.00 |
| 2022-07-01 | Thorell Marella | director: | 38,023 | A-Award | A | 38,023 | 0.00 | 0.00 |
| 2022-06-09 | Ammer Richard | director: | 7,500 | A-Award | A | 7,500 | 0.00 | 0.00 |
| 2022-06-09 | Payne Joseph E | director: | 7,500 | A-Award | A | 7,500 | 0.00 | 0.00 |
| 2022-06-09 | Thorell Marella | director: | 7,500 | A-Award | A | 7,500 | 0.00 | 0.00 |
| 2022-06-09 | Thorell Marella | director | 7,500 | A-Award | A | 7,500 | 0.51 | 3,825.00 |
| 2022-02-23 | Chhabra Meenu | director | 15,000 | A-Award | A | 15,000 | 7.67 | 115,050.00 |
| 2022-02-23 | Chhabra Meenu | director: | 0 | 0 | 0.00 | 0.00 | ||
| 2022-02-15 | Baker David Charles | director, officer: Chief Executive Officer | 61,000 | A-Award | A | 61,000 | 5.63 | 343,430.00 |
| 2022-02-15 | Kelly Leanne M. | officer: Chief Financial Officer | 50,000 | A-Award | A | 50,000 | 5.63 | 281,500.00 |
| 2021-06-04 | Kelly Leanne M. | officer: Chief Financial Officer | 6,250 | P-Purchase | A | 1,508 | 4.08 | 6,153.00 |
| 2021-06-03 | Kelly Leanne M. | officer: Chief Financial Officer | 4,742 | P-Purchase | A | 1,085 | 4.05 | 4,394.00 |
| 2021-06-02 | Kelly Leanne M. | officer: Chief Financial Officer | 3,657 | P-Purchase | A | 3,657 | 4.00 | 14,628.00 |
| 2021-05-26 | Payne Joseph E | director | 17,500 | P-Purchase | A | 6,800 | 4.50 | 30,600.00 |
| 2021-05-25 | Payne Joseph E | director | 10,700 | P-Purchase | A | 10,700 | 3.85 | 41,195.00 |
| 2021-05-14 | Payne Joseph E | director | 15,000 | A-Award | A | 15,000 | 3.66 | 54,900.00 |
| 2021-05-14 | Payne Joseph E | director | 14,286 | A-Award | A | 14,286 | 3.66 | 52,287.00 |
| 2021-05-14 | Ammer Richard | director | 15,000 | A-Award | A | 15,000 | 3.66 | 54,900.00 |
| 2021-05-14 | Ammer Richard | director | 10,204 | A-Award | A | 10,204 | 3.66 | 37,347.00 |
| 2021-05-14 | Levi Ofir | director | 30,000 | A-Award | A | 30,000 | 3.66 | 109,800.00 |
| 2021-05-14 | Levi Ofir | director | 15,000 | A-Award | A | 15,000 | 3.66 | 54,900.00 |
| 2021-05-14 | Kelly Leanne M. | officer: Chief Financial Officer | 70,000 | A-Award | A | 70,000 | 3.66 | 256,200.00 |
| 2021-05-14 | Toren Penny | officer: SVP, Regul Affairs & Prog Mgmt | 25,000 | A-Award | A | 25,000 | 3.66 | 91,500.00 |
| 2021-05-14 | Baker David Charles | director, officer: Chief Executive Officer | 100,000 | A-Award | A | 100,000 | 3.66 | 366,000.00 |
| 2021-05-11 | Kelly Leanne M. | officer | 0 | 0 | 0.00 | 0.00 | ||
| 2021-02-12 | Ammer Richard | director | 47,063 | J-Other | A | 47,063 | 6.40 | 301,203.00 |
| 2021-02-12 | SALMON Pharma GmbH | 10 percent owner | 47,063 | J-Other | A | 47,063 | 6.40 | 301,203.00 |
| 2021-02-12 | Thorell Marella | director | 15,000 | A-Award | A | 15,000 | 8.00 | 120,000.00 |
| 2021-02-12 | Baker David Charles | director, officer: Chief Executive Officer | 8,843 | P-Purchase | A | 1,000 | 8.00 | 8,000.00 |
| 2021-02-12 | Baker David Charles | director, officer: Chief Executive Officer | 7,843 | J-Other | A | 7,843 | 6.40 | 50,195.00 |
| 2021-02-09 | Payne Joseph E | director, 10 percent owner: | 843,750 | I | 0 | 0.00 | 0.00 | |
| 2021-02-09 | Arcturus Therapeutics Holdings Inc. | 10 percent owner | 843,750 | D | 0 | 0.00 | 0.00 | |
| 2021-02-09 | Thorell Marella | director: | 0 | 0 | 0.00 | 0.00 | ||
| 2019-01-15 | Baker David Charles | director, officer: Chief Executive Officer | 0 | D | 46,875 | 1.84 | 86,250.00 | |
| 2021-02-04 | Baker David Charles | director, officer: Chief Executive Officer | 0 | D | 61,250 | 2.20 | 134,750.00 | |
| 2021-02-09 | Levi Ofir | director | 196,875 | D | 0 | 0.00 | 0.00 | |
| 2021-02-09 | Ammer Richard | director, 10 percent owner: | 1,476,734 | I | 0 | 0.00 | 0.00 | |
| 2021-02-09 | SALMON Pharma GmbH | 10 percent owner | 1,476,734 | D | 0 | 0.00 | 0.00 | |
| 2018-10-01 | Toren Penny | officer: SVP, Regul Affairs & Prog Mgmt | 0 | D | 7,813 | 1.84 | 14,376.00 | |
| 2021-02-09 | Toren Penny | officer: SVP, Regul Affairs & Prog Mgmt | 0 | D | 5,000 | 3.82 | 19,100.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
